Impact of Peritoneal Dialysis Treatment on Arterial Stiffness and Vascular Changes in Diabetic Type 2 and Nondiabetic Patients with End-Stage Renal Disease

Table 2

Parameters of peritoneal dialysis before and after 12 months of treatment in patients with DM type 2 and without of DM.

Variable	Without DM		With DM type 2
	Basal	After 12 months	Basal	After 12 months
Diuresis (mL)	626.0±383.0	714.0±479.3^∗	465±363.9^∗∗	362.0±273.6^∗†
RRF (mL/min)	6.1±3.8	8.0±3.9^∗	4.9±3.2^∗∗	4.9±3.9^†
Creatinine (μmol/L)	838.5±253.2	714.5±154.0^∗	986.2±162.3^∗∗	815.2±109.3^∗†
𝐾𝑡/𝑉urea < 1.7	3 (12.0%)		1 (4.0%)	2 (8.0%)
𝐾𝑡/𝑉urea 1.7–2.0	3 (12.0%)	4 (16.0%)	18 (72.0%)	14 (56.0%)
𝐾𝑡/𝑉urea > 2.0	19 (76.0%)	21 (84.0%)	6 (24.0%)**	9 (36.0%)^†
Low-average transporters (T)	23 (92.0%)	24 (96.0%)	11 (44.0%)	11 (44.0%)
High-average T	1 (4.0%)	1 (4.0%)	10 (40.0%)	8 (32.0%)
High T			4 (16.0%)**	6 (24.0%)^†

∗Significant difference in the same group before (basal) and 12 months after PD treatment.
**Significant difference between groups before the PD treatment.
^†Significant difference between groups 12 months after PD treatment.
RRF: residual renal function.